Freestone Grove Partners’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,229
Closed -$196K 1229
2026
Q1
$196K Buy
+1,229
New +$189K ﹤0.01% 738

Other funds holding NHC

Freestone Grove Partners's NHC Position: Q2 2026 in Review

Freestone Grove Partners sold out of National Healthcare (NHC) in Q2 2026, closing a stake of 1,229 shares — an estimated $196K sold.

Freestone Grove Partners first reported a position in NHC in Q1 2026 and held it in 1 quarter. The position peaked at $196K in Q1 2026. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Freestone Grove Partners reported no remaining National Healthcare position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1,229 National Healthcare shares in Q2 2026, an estimated $196K.
  • Freestone Grove Partners first reported a position in National Healthcare in Q1 2026 and held it in 1 quarter.
  • Freestone Grove Partners's National Healthcare position peaked at $196K in Q1 2026.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.